Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 4Head and Neck Neoplasms 3Pain 2Depression 2Breast Neoplasms 2Stomatitis 1Pancreatic Neoplasms 1Pain, Postoperative 1Mucositis 1Lung Neoplasms 1Choledocholithiasis 1Choledochal Cyst 1Cholangitis 1Cancer Pain 1Anxiety Disorders 1Agnosia 1

Interventions

Morphine 2resiniferatoxin 1incobotulinumtoxinA 1fulranumab 1cannabichromene 1alvimopan 1Tablets 1Surveys and Questionnaires 1Standard of Care 1Pain Management 1Oxycodone 1Occupational Therapy 1Massage 1Lidocaine 1Lenalidomide 1Ketamine 1Gels 1Fentanyl 1Dronabinol 1Cannabidiol 1Animal Assisted Therapy 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Cancer Pain × Ketamine × Clear all
NCT03362073 2021-09-28

CIVIK

Pusan National University Yangsan Hospital

Phase 2 Unknown
26 enrolled

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡